Log In Sign up
The largest database of trusted experimental protocols

Recombinant mouse il 33

Manufactured by Thermo Fisher Scientific
Visit Supplier

Recombinant mouse IL-33 is a protein produced using recombinant DNA technology. It is a member of the IL-1 cytokine family and plays a role in immune response regulation.

Automatically generated - may contain errors

Lab products found in correlation

Recombinant mouse il 2, by Thermo Fisher Scientific (2 mentions) Anti mouse il 2 antibody, by Thermo Fisher Scientific (2 mentions) Recombinant mouse il 25, by R&D Systems (2 mentions)

Spelling variants of this product

IL-33 (117 citations) Recombinant IL-33 (15 citations) Mouse IL-33 (3 citations)

2 protocols using recombinant mouse il 33

1

Immunomodulatory Effects of IL-2c and Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-2c was prepared by combining 0.5 mg recombinant mouse IL-2 (eBioscience) with 5 mg anti-mouse-IL-2 antibody (eBioscience) and incubated at 37°C for 15 minutes. Mice were treated with isotype control, IL-2c, 0.5 mg recombinant mouse IL-33 (Invitrogen), IL-2c in combination with IL-33, 0.5 mg recombinant mouse IL-25 (R and D systems), or IL-2c in combination with IL-25 (Price et al., 2010 (link)). Mice in all treatment groups were administered agents intraperitoneally starting at 2 weeks of age. Animals were injected every other day for a total of 3 injections and were euthanized at 4 weeks of age.
Kastenschmidt J.M., Coulis G., Farahat P.K., Pham P., Rios R., Cristal T.T., Mannaa A.H., Ayer R.E., Yahia R., Deshpande A.A., Hughes B.S., Savage A.K., Giesige C.R., Harper S.Q., Locksley R.M., Mozaffar T, & Villalta S.A. (2021). A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression. Cell reports, 35(2), 108997.
+ Open protocol
+ Expand
2

Immunomodulatory Effects of IL-2c and Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-2c was prepared by combining 0.5 mg recombinant mouse IL-2 (eBioscience) with 5 mg anti-mouse-IL-2 antibody (eBioscience) and incubated at 37°C for 15 minutes. Mice were treated with isotype control, IL-2c, 0.5 mg recombinant mouse IL-33 (Invitrogen), IL-2c in combination with IL-33, 0.5 mg recombinant mouse IL-25 (R and D systems), or IL-2c in combination with IL-25 (Price et al., 2010 (link)). Mice in all treatment groups were administered agents intraperitoneally starting at 2 weeks of age. Animals were injected every other day for a total of 3 injections and were euthanized at 4 weeks of age.
Kastenschmidt J.M., Coulis G., Farahat P.K., Pham P., Rios R., Cristal T.T., Mannaa A.H., Ayer R.E., Yahia R., Deshpande A.A., Hughes B.S., Savage A.K., Giesige C.R., Harper S.Q., Locksley R.M., Mozaffar T, & Villalta S.A. (2021). A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression. Cell reports, 35(2), 108997.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!